SK Group merges affiliates to launch US-based CMO

Published: 3-Sep-2019
Manufacturing Finance

The South Korea-based group will launched the new entity in 2020 to be called SK Pharmteco, based in Sacramento, California

South Korea-based SK Group has announced it will launch a US-based company to handle its three medical CMO affiliates in the country.

Aju Business Dailey said that the business move is aimed at enhancing synergy and efficiency by simplifying the governance structure.

The new entity will be called SK Pharmteco and will be based in Sacramento, California.

SK Pharmteco is expected to launch in January 2020.

SK Holdings, which owns the SK Group, said that it expects the integration would help enhance its competitiveness in the global medical producing market and improve cost efficiency.

The company also owns SK Biopharmaceuticals, SK Biotek, SK Biotek Ireland, SK Biotek USA and AMPAC.

  • Companies:
  • SK pharmteco
See more

You may also like

Manufacturing

SK pharmteco subsidiary Yposkesi launches AAVelocity, a plug-and-play AAV platform

Read more
Designed to shorten turnaround on manufacturing AAVs, this new platform offers CGT developers more flexibility when producing viral vectors for clinical and commercial use

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

SK pharmteco subsidiary Yposkesi launches AAVelocity, a plug-and-play AAV platform

Designed to shorten turnaround on manufacturing AAVs, this new platform offers CGT developers more flexibility when producing viral vectors for clinical and commercial use
Manufacturing

Anton Paar expands Litesizer DIA Series with new models

Introducing affordable and advanced solutions for particle analysis
Manufacturing

Triple your efficiency with the new DrySyn Vortex

Boost productivity with temperature-controlled parallel reactions
Manufacturing

Five critical design elements for Pelton wheel turbine flowmeters

Titan Enterprises outlines the factors for cost-effective and reliable low-flow measurement
Manufacturing

Automated feeding: a scalable, affordable solution to low manufacturing productivity

In the UK, productivity is languishing and workforce shortages are significant. No sector understands this more than manufacturing, which had a staggering 74,000 vacancies in 2023, contributing to the increasing cost of production
Manufacturing

Hovione nearly doubles pharmaceutical spray drying capabilities at Cork, Ireland facility

The CDMO's multi-million investment will allow it to significantly increase its spray drying capacity, which is necessary for inhaled and oral therapeutics
Manufacturing

CDMO Adragos Pharma acquires aseptic fill-finish manufacturing expert, Baccinex

Baccinex has significant knowledge in sterile fill-finish processes for both lyophilised and liquid vials
Subscribe now